LeadIQ logo
Learn more at LeadIQ.com

Insights

Partnership Potential Collaboration with Novo Nordisk presents partnership potential for Ascendis Pharma in clinical development and commercialization, offering opportunities for strategic alliances and market expansion.

Investment Attraction Receiving investments from Perceptive Advisors LLC signifies market interest, reflecting investor confidence in Ascendis Pharma's growth potential and creating opportunities for further financial backing and business development.

Therapeutic Innovation Recent launches of innovative medical treatments like Yorvipath and TransCon ophthalmology assets indicate Ascendis Pharma's focus on therapeutic innovation, opening doors for collaborations with healthcare providers and expanded market reach.

Revenue Growth Initiatives Expansion into endocrinology therapies and the formation of strategic partnerships with companies like Specialised Therapeutics Asia demonstrate Ascendis Pharma's revenue growth initiatives, offering opportunities for new product distribution channels and market penetration in key regions.

Competitive Advantage Ascendis Pharma's technology platform and product launches position the company favorably against competitors like AstraZeneca and Vertex Pharmaceuticals, creating opportunities for gaining market share, attracting top talent, and further solidifying its competitive advantage.

Similar companies to Ascendis Pharma

Ascendis Pharma Tech Stack

Ascendis Pharma uses 8 technology products and services including SAS/STAT, Cloudflare, Shopify, and more. Explore Ascendis Pharma's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • Cloudflare
    Content Management System
  • Shopify
    E-commerce
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • C#
    Programming Languages
  • Adobe Creative Suite
    Visualisation Software
  • Zoom
    Web Conferencing

Media & News

Ascendis Pharma's Email Address Formats

Ascendis Pharma uses at least 2 format(s):
Ascendis Pharma Email FormatsExamplePercentage
FL@ascendispharma.comJD@ascendispharma.com
49%
FLast@ascendispharma.comJDoe@ascendispharma.com
34%
LF@ascendispharma.comDJ@ascendispharma.com
10%
FiLast@ascendispharma.comJoDoe@ascendispharma.com
7%
First.Last@ascendispharma.co.zaJohn.Doe@ascendispharma.co.za
100%

Frequently Asked Questions

Where is Ascendis Pharma's headquarters located?

Minus sign iconPlus sign icon
Ascendis Pharma's main headquarters is located at Tuborg Boulevard 12 Hellerup, Capital Region of Denmark 2900 DK. The company has employees across 4 continents, including EuropeNorth AmericaAfrica.

What is Ascendis Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Ascendis Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ascendis Pharma's stock symbol?

Minus sign iconPlus sign icon
Ascendis Pharma is a publicly traded company; the company's stock symbol is ASND.

What is Ascendis Pharma's official website and social media links?

Minus sign iconPlus sign icon
Ascendis Pharma's official website is ascendispharma.com and has social profiles on LinkedIn.

How much revenue does Ascendis Pharma generate?

Minus sign iconPlus sign icon
As of September 2024, Ascendis Pharma's annual revenue reached $750M.

What is Ascendis Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Ascendis Pharma's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ascendis Pharma have currently?

Minus sign iconPlus sign icon
As of September 2024, Ascendis Pharma has approximately 974 employees across 4 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Information Officer: L. T. P.Chief Business Officer: S. G.Vice President Of Market Access: J. P.. Explore Ascendis Pharma's employee directory with LeadIQ.

What industry does Ascendis Pharma belong to?

Minus sign iconPlus sign icon
Ascendis Pharma operates in the Biotechnology Research industry.

What technology does Ascendis Pharma use?

Minus sign iconPlus sign icon
Ascendis Pharma's tech stack includes SAS/STATCloudflareShopifyTwitter Emoji (Twemoji)Google Font APIC#Adobe Creative SuiteZoom.

What is Ascendis Pharma's email format?

Minus sign iconPlus sign icon
Ascendis Pharma's email format typically follows the pattern of . Find more Ascendis Pharma email formats with LeadIQ.

How much funding has Ascendis Pharma raised to date?

Minus sign iconPlus sign icon
As of September 2024, Ascendis Pharma has raised $281M in funding. The last funding round occurred on Sep 19, 2024 for $281M.

When was Ascendis Pharma founded?

Minus sign iconPlus sign icon
Ascendis Pharma was founded in 2007.
Ascendis Pharma

Ascendis Pharma

Biotechnology ResearchCapital Region of Denmark, Denmark501-1000 Employees

Ascendis Pharma is applying our innovative TransCon technology platform to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our TransCon technology platform to create new and potentially best-in-class therapies.

Ascendis Pharma currently has three independent endocrinology rare disease product candidates in clinical development and we're also advancing programs in Oncology and Ophthalmology. 

Ascendis Pharma is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg, Munich, and Berlin, Germany, Palo Alto and Redwood City, California, and Princeton, New Jersey.

Section iconCompany Overview

Headquarters
Tuborg Boulevard 12 Hellerup, Capital Region of Denmark 2900 DK
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ASND
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
501-1000

Section iconFunding & Financials

  • $281M

    Ascendis Pharma has raised a total of $281M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $281M.

  • $100M$1B

    Ascendis Pharma's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $281M

    Ascendis Pharma has raised a total of $281M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $281M.

  • $100M$1B

    Ascendis Pharma's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.